Company / Shares Outstanding
Taysha Gene Therapies, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
204.9M
FY2025
5-year range
37.7M / 204.9M
FY2021-FY2025
Trend
+9.6%
vs FY2024
Sector context
#43 of 212
Health Care
What the data says
Taysha Gene Therapies, Inc.'s shares outstanding of 204943306.00 is higher than 80% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 5 consecutive years, from 17665683.00 in FY2020 to 204943306.00 in FY2025.
Based on SEC 10-K filings.
204943306.00 in FY2025 with a 5-year CAGR of +63.3%. Top quartile in the Health Care sector.
Increased from 63207507.00 to 204943306.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +74.6%
- 5-Year CAGR
- +63.3%
- 10-Year CAGR
- -
Sector benchmark
-33.2% below sector average
Key checks
Key Insights
- Taysha Gene Therapies, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 9.6% year-over-year.
- Ranks #43 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 204.9M | +9.6% |
| FY2024 | 187.0M | +195.8% |
| FY2023 | 63.2M | +64.3% |
| FY2022 | 38.5M | +2.2% |
| FY2021 | 37.7M | +113.1% |
| FY2020 | 17.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026